Impact of Partial-Volume Effect Correction on the Predictive and Prognostic Value of Baseline 18F-FDG PET Images in Esophageal Cancer
Open Access
- 2 January 2012
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 53 (1), 12-20
- https://doi.org/10.2967/jnumed.111.092775
Abstract
The objective of this study was to investigate the clinical impact of partial-volume effect (PVE) correction on the predictive and prognostic value of metabolically active tumor volume (MATV) measurements on 18F-FDG PET baseline scans for therapy response and overall survival in esophageal cancer patients. Methods: Fifty patients with esophageal cancer treated with concomitant radiochemotherapy between 2004 and 2008 were retrospectively considered. PET baseline scans were corrected for PVE with iterative deconvolution incorporating wavelet denoising. MATV delineation on both original and corrected images was performed using the automatic fuzzy locally adaptive Bayesian methodology. Several parameters were extracted considering the original and corrected images: maximum and peak standardized uptake value (SUV), mean SUV, MATV, and total lesion glycolysis (TLG) (TLG = MATV × mean SUV). The predictive value of each parameter with or without correction was investigated using Kruskal–Wallis tests, and the prognostic value was determined with Kaplan–Meier curves. Results: Whereas PVE correction had a significant quantitative impact on the absolute values of the investigated parameters, their clinical value within the clinical context of interest was not significantly modified—a result that was observed for both overall survival and response to therapy. The hierarchy between parameters was the same before and after correction. SUV measurements (maximum, peak, and mean) had nonsignificant (P > 0.05) predictive or prognostic value, whereas functional tumor-related measurements (MATV and TLG) were significant (P < 0.002) predictors of response and independent prognostic factors. Conclusion: PVE correction does not improve the predictive and prognostic value of baseline PET image–derived parameters in esophageal cancer patients.Keywords
This publication has 37 references indexed in Scilit:
- Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal CarcinomaAnnals of Surgical Oncology, 2009
- Prediction of Metastatic Disease and Survival in Patients with Gastric and Gastroesophageal Junction Tumors: The Incremental Value of PET-CT over PET and the Clinical Role of Primary Tumor Volume MeasurementsAcademic Radiology, 2009
- Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal CancerJournal of Clinical Oncology, 2007
- Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisThe Lancet Oncology, 2007
- Targeted Agents and Esophageal Cancer—The Next Step?Seminars in Radiation Oncology, 2007
- Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramThe Oncologist, 2007
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion GlycolysisClinical Positron Imaging, 1999